Suspension of trading
Centessa Pharmaceuticals plc Share Price
Stocks
CNTA
US1523091007
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.50 USD | +0.80% |
|
-.--% | +61.94% |
| 06-24 | Swiss Market Index Extends Rally; OC Oerlikon Shares Gain | MT |
| 06-24 | Eli Lilly Completes Acquisition of Centessa Pharmaceuticals | MT |
| Market Cap | 6.27B 5.51B 5.12B 4.71B 8.82B 605B 8.99B 61.03B 23.84B 295B 23.52B 23.02B 1,027B | P/E 2024 |
-8.13x | P/E 2025 | -17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 6.09B 5.35B 4.97B 4.57B 8.58B 588B 8.74B 59.31B 23.17B 287B 22.86B 22.37B 998B | EV / Sales 2024 |
-
| EV / Sales 2025 | 231,810,355x |
| Free-Float |
78.43% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.80% | ||
| 1 month | +0.80% | ||
| 3 months | +2.61% | ||
| 6 months | +64.30% | ||
| Current year | +61.94% |
| Current year | 21.5 |  | 40.56 |
| 1 year | 15.01 | | 40.56 |
| 3 years | 5.15 | | 40.56 |
| 5 years | 2.88 | | 40.56 |
| 10 years | 2.88 | | 40.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charlene Stoudt
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/2024 |
Tia Bush
CTO | Chief Tech/Sci/R&D Officer | 55 | 28/02/2023 |
David Chao
ADM | Chief Administrative Officer | 58 | 31/03/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 23/06/2026 | |
Kristina Wright
BRD | Director/Board Member | - | 23/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24/06/26 | Issuer sale | Controller/Auditor | -218,000 | 0.1409% | ||
| 24/06/26 | Issuer sale | Chief Technology Officer | -620,000 | 0.4007% | ||
| 24/06/26 | Issuer sale | Director | -392,474 | 0.2537% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | -.--% | +150.46% | +454.79% | 6.27B | |
| +1.08% | -6.74% | -2.31% | +10.45% | 46.06B | |
| +3.13% | +2.34% | +393.21% | +605.08% | 38.91B | |
| +2.14% | +4.98% | +10.55% | +65.45% | 35.57B | |
| +4.43% | +0.25% | +10.64% | -9.17% | 33.13B | |
| +1.23% | -1.99% | -0.05% | +30.76% | 26.42B | |
| +0.29% | -5.92% | - | - | 16.61B | |
| +14.71% | +14.47% | +26.81% | +146.99% | 15.08B | |
| -6.32% | -4.59% | +4.36% | +8.22% | 14.08B | |
| +1.82% | -1.02% | +5.46% | -30.74% | 12.81B | |
| Average | +2.11% | -1.72% | +66.57% | +142.43% | 24.49B | |
| Weighted average by Cap. | +2.06% | -2.36% | +76.20% | +138.62% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 15 13.18 12.25 11.27 21.12 1.45K 21.53 146.09 57.05 707.32 56.3 55.09 2.46K |
| Net income | -236M -207M -193M -177M -332M -22.77B -338M -2.3B -897M -11.12B -885M -866M -38.62B | -198M -174M -161M -148M -278M -19.07B -283M -1.92B -751M -9.31B -741M -726M -32.36B |
| Net Debt | -364M -320M -298M -274M -513M -35.18B -523M -3.55B -1.39B -17.18B -1.37B -1.34B -59.69B | -176M -155M -144M -132M -248M -17.01B -253M -1.72B -670M -8.31B -661M -647M -28.87B |
Employees
129
- Stock Market
- Stocks
- CNTA Stock
Select your edition
All financial news and data tailored to specific country editions
